Short answer
Pfizer Inc (PFE) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CFO Dave Denton departing August 15, 2026 for consumer-goods opportunity outside pharmaceuticals.
Pfizer Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CFO Dave Denton departing August 15, 2026 for consumer-goods opportunity outside pharmaceuticals
- Departure explicitly unrelated to Pfizer’s financial results, operations, or accounting disagreements
- Cecile Guegan becoming interim CFO August 16, 2026
- Comprehensive search underway for permanent CFO successor
- Leadership transition creates near-term investor focus on continuity of financial strategy and reporting പങ്ക
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pfizer Inc 8-K filings
Get the next PFE 8-K as it lands
Follow PFE for push alerts, or ask the research agent what this filing means.